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water ad libitum. This study was conducted in accordance with the National Institute of Health guidelines for the care and use of animals in research and under protocols approved by the Center for Laboratory Animal Care at the University of Connecticut Health Center.
Focal Cerebral Ischemic Model
Focal transient cerebral ischemia was induced by 60-minute MCAO under isoflurane anesthesia as described previously. 11 Silicone-coated sutures (0.21 and 0.23 mm) were used in young and aged mice, respectively, to achieve occlusion. 4 Rectal temperature was maintained at ≈37°C during surgery with an automated temperature control feedback system. Animals that did not show any decrease in CBF by LSF after suture insertion were excluded from the study.
Laser Speckle Flowmetry
Laser speckle perfusion imaging of the brain was performed using moorFLPI Full-Field Laser Perfusion Imager (Moor Instruments, Devon, UK) according to the manufacturer's instructions and as described previously. 10 Briefly, a midline scalp incision was made to an isoflurane-anaesthetized mouse and the skull was exposed; the charge coupled device camera of LSF was installed 30 cm above the skull using an articulating arm. Two identical rectangular regions of interest were selected on each of the 2 hemispheres ( Figure 1A ). The imaging was set up at a display rate of 25 Hz, time constant of 1 second, and a camera exposure time of 4 milliseconds. A 2-minute baseline CBF flux was recorded before induction of ischemia. MCAO surgery was performed and live image and flux recordings were made throughout the intraischemic and postreperfusion periods. Data were expressed as mean CBF flux of 2 minutes of preischemic period, 50 minutes of intraischemic period, and 2 minutes of postreperfusion period after 10-minute reperfusion. Neurological deficit scores were recorded 24 hours after MCAO 11 : 0, no deficit; 1, forelimb weakness and torso turning to the ipsilateral side when held by tail; 2, circling to affected side; 3, unable to bear weight on affected side; and 4, no spontaneous locomotor activity or barrel rolling.
Terminal Histopathology and IgG Staining
One cohort of mice was euthanized at 24 hours after MCAO and a second cohort was euthanized at a 72-hour end point. The brains were perfused with cold PBS followed by 4% paraformaldehyde. The brains were then postfixed in paraformaldehyde for 24 hours and placed in cryoprotectant (30% sucrose), frozen and then sliced into 30-μm free-floating sections on a freezing microtome. Every eighth section was stained with cresyl violet stain to evaluate ischemic cell damage, as described previously. 12 IgG staining shows BBB compromise. 13 Brain sections were stained with IgG, as described previously. 13 Briefly, first endogenous peroxidase activity was blocked using 1% H 2 O 2 and then incubated with biotinylated antimouse antibody (Vector Laboratories) for 30 minutes, rinsed in PBS, and incubated in Vectastain ABC reagent for 30 minutes followed by 1-minute hematoxylin counterstaining. After rinsing in PBS, the reaction product was visualized using 3,3'-diaminobenzidine (DAB) staining 14 and images were captured using the MicroPublisher 5.0 RTV (Q Imaging) brightfield microscope with the Metamorph software (Universal Imaging Corporation). Sections were quantified subsequently by a blinded observer using SigmaScan Pro (version 5.0) image measurement software. The area of DAB signal on the ipsilateral hemisphere was measured and IgG extravasation was calculated as the ratio of DAB signal/total hemispheric area.
FITC-Dextran Staining
A total of 150 kDa FITC-dextran (Sigma) was injected through the femoral vein of mice at 24 hours of MCAO. The mice were then euthanized by cervical dislocation (after 2 minutes of injection) and the brains were harvested and flash frozen in 2-methylbutane on dry ice. Frozen brains were then embedded in optimal cutting temperature embedding solution and cut into 10-μm sections on a cryostat at -19°C and mounted on charged slides. 15 Every eighth section was cover slipped and used to visualize and quantify FITC-dextran staining.
Immunohistochemistry
Immunohistochemical staining of frozen fixed sections (30 μm) was performed as described previously. 6, 16, 17 Briefly, brain slices were mounted onto gelatin-coated slides, allowed to air dry, and then blocked in 0.1 mol/L phosphate buffer with 0.3% TritonX-100 (Sigma) and 10% donkey serum for an hour. Primary antibody (CD31, Sigma, 1:500) was added overnight. After washes, the sections were incubated with secondary antibody (1:1000) and 4′,6-diamidino-2-phenylindole, dihydrochloride (DAPI, 1:1000, 
Fluorescent Microscopy
FITC-dextran and CD31 images were acquired with a Zeiss Axiovert 200 mol/L microscope (Carl Zeiss, Oberkochen, Germany) using a X-Cite 120Q fluorescence illumination system (Lumen Dynamics Group Inc, Mississauga, ON, Canada) and Zeiss image acquisition software (Zeiss LSM 510).
Brain slices were taken at the same distance from bregma (0.5 mm anterior to bregma) and 3 (20×) fields per animal were analyzed by a blinded observer in the penumbral area of the infarct. Microvascular density was evaluated by calculating the integrated pixel density of the images using MacBiophotonics ImageJ software. The average of the integrated pixel density of 3 fields of view (20×) was used for the analysis.
Statistical Analysis
Flux data are presented as mean±SEM. CBF flux percentage was calculated by normalizing the baseline preischemic flux to 100% and expressing the intraischemic and postreperfusion flux as a percentage of the baseline. Two-way ANOVA with factors of aging (young and aged) and stroke (prestroke, intraischemic, and postreperfusion) was used. The ordinal data (neurological score) is expressed as median (interquartile) and was analyzed using Mann-Whitney U test on SPSS software (version 20). Integrated pixel density and IgG immunoreactivity were analyzed by t test with unequal variance. P<0.05 was considered statistically significant. 
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Results
CBF Flux in the Brain After Stroke
LSF was performed in both young and aged mice subjected to 60-minute MCAO ( Figure 1A and 1B). One mouse that did not show ischemia by LSF was excluded, and the mortality was 5% by the end of this experiment. There was no significant effect of aging on the CBF flux in the ipsilateral hemisphere ( 
Neurological Scores Are Worse in the Aged Mice
The neurological deficit was scored 24 and 72 hours after stroke. At 24 hours of stroke, aged mice had significantly worse neurological scores, 4 (0) versus 1 (0.5) in young mice (P<0.05). There was no significant difference in the weight loss between young (5.7±1.5%) and aged (6.8±1.3%) mice at 24 hours after MCAO. The same pattern was also seen in 72-hour cohort.
FITC Dextran and CD31 Show No Difference in Microvascular Density
To confirm the LSF data that there was no difference in CBF flux between young and aged mice after stroke, we further examined the integrity of microvasculature in both cohorts. FITC-dextran staining found dextran localized along the vessels; there was no significant difference in dextran-integrated pix density between the young and aged cohorts (Figure 4B and 4C; P<0.05; 9 images from 3 brains were analyzed). We further assessed the microvasculature using CD31 staining. The integrated vessel density was not significantly different in young versus aged mice (Figure 5A and 5B; P<0.05; 9 images from 3 brains were analyzed). This suggests that structural differences pertaining to vessel density do not exist in young versus aged mice. 
BBB Breakdown Is Higher in Young Mice
Because we found no difference in the perfusion but worse neurological scores in the aged mice, we wanted to explore the integrity of the BBB in these mice using IgG staining. Figure 6A shows representative coronal brain sections of cresyl violet staining. Figure 6B shows IgG staining in mice euthanized at 24 and 72 hours of MCAO, respectively (n=5 in aged and n=6 in young group). Significantly higher IgG immunoreactivity was seen in young versus aged mice post stroke, indicating higher BBB leakage in young brains (P<0.05; Figure 6C and 6D).
Discussion
This study is the first to use LSF to monitor CBF changes in the brains of aged mice peri-ischemia. Several important novel findings were found. First, by the functional analysis of CBF with LSF, we established that the different stroke phenotypes between young and aged animals seen in this study and previous reports 6, 18 are not because of different levels of ischemia in young versus aged brains. Second, the structural analysis of CBF with FITC-dextran and CD31 staining also revealed that the cerebral microvascular density is not different in young versus aged animals after MCAO. Third, our LSF data demonstrated that the unilateral MCAO not only induces infarction in the ipsilateral hemisphere, but also causes CBF reduction in the contralateral hemisphere, indicating a widespread and diffuse change that occurs throughout the brain and vasculature even in focal stroke models. Finally, we found that aged male mice have less IgG extravasation at both the acute and subacute stages of stroke as compared with the young animals, suggesting that there was less BBB breakdown in the aged ischemic brains.
It is increasingly accepted that modeling stroke in aged animals more appropriately mimics patients with stroke. However, stroke studies in aged animals are often not performed because of the high cost of aging animals and technical expertise required for surgeries. The few studies available in the literature have shown varying results in the histological outcomes in young versus aged animal. 4, 6, [19] [20] [21] [22] [23] There have been reports of increased, 22, 24 equal, 23, 25 or decreased infarct volumes 4, [19] [20] [21] in aged versus young animals. The discrepancies may be because of the difference in animal strains, animal sexes, or ischemic models used in the studies. Several clinical studies 7, 26 demonstrated that age negatively correlated with the size of either the ischemic lesion or the penumbral area in patients with stroke, which is consistent with the results from our studies. Despite discrepancies in histological outcomes, there is agreement in most preclinical and clinical studies that functional (behavioral) stroke outcomes are worse in aged cohorts. 2, 6, 22, 27 The underlying mechanism remains elusive and may be because of age-related comorbidities, an increased systemic immune response, 28 autonomic or cardiac instability, 29 and decreased neurogenesis/angiogenesis, 8 all of which have been well documented in aged animals. 
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Aging is associated with structural alterations in the vessel wall (intima and smooth muscle cells), which leads to arterial stiffening, endothelial dysfunction, atherosclerosis, and calcification of vessels. [30] [31] [32] Therefore, it was physiologically plausible that there may be a structural difference in the cerebral vasculature and also a functional difference in the cerebral perfusion either at the baseline and in the setting of an ischemic injury, leading to smaller infarcts in the aged. However, both functional and structural analysis of CBF perfusion performed in the present study did not support this hypothesis. We did not see differences in the baseline, intraischemic, and postreperfusion CBF between the young and aged cohorts, consistent with clinical studies that showed CBF did not decline with age in the healthy individuals 33 and that there were no differences in CBF in young and aged patients with acute stroke. 7 Thus, it seems that age-related changes in the vascular bed do not significantly change the perfusion of the brain territories before or after stroke, and neither does the aged brain seem to have enhanced collateral-mediated reperfusion intraischemically, suggesting that other molecular mechanisms downstream to ischemia instead of CBF changes may be involved in mediating the age-dependent stroke injury. 5, 16 Interestingly, our LSF data revealed that CBF in the contralateral hemisphere also significantly dropped from the baseline after stroke, which exemplifies the fact that stroke is a systemic disease and that the ischemic challenge may be sensed throughout the vasculature. Systemic changes in distant organs (eg, the spleen) induced by stroke have been increasingly reported 34, 35 and are most likely mediated by activated molecules or metabolites released from the ischemic brain tissue into the circulation.
The amount of plasma protein IgG leakage correlated with infarct volumes. Less IgG extravasation was seen in the aged brain indicating less BBB breakdown, consistent with our previous finding that Evans blue extravasation was significantly less in aging versus young ischemic brains. 4 It is interesting that despite similar intraischemic reductions in CBF, the BBB integrity was less compromised in the aged brain. Expression of connexin 43, a major gap junction protein and a key component of BBB, was reduced in young mice but preserved in aging brains after ischemic stroke. 18 Although aging has deleterious effect on BBB function under normal conditions, 36 young brains may still have more robust BBB breakdown after ischemia because of the enhanced inflammatory responses compared with aged brains. 20 However, whether the relatively preserved BBB integrity in the aged brain is a result of less ischemic injury or vice versa remains unknown. Experimental studies 37, 38 found that the inhibition of matrix metalloproteinase-9, a proteolytic enzyme that degrades the BBB, is neuroprotective by reducing infarct size, suggesting that BBB integrity is important in limiting the ischemic lesion. The possibility could not be excluded that the less injured BBB in aged ischemic brains may be causative to the smaller infarct compared with young brains in the present study. Future studies are needed to examine age-related BBB changes after ischemia.
There are several limitations to this work that need to be recognized when interpreting our data. We only used LSF for the functional analysis of CBF, as LSF allows us to monitor the CBF change intraischemically in a live animal.14C-iodoantipyrine autoradiography is a more accurate and quantitative method to examine brain tissue reperfusion after ischemia. 39 However, we did not elect to do this because 14C-iodoantipyrine autoradiography is a terminal study and cannot be used to monitor CBF in real-time preischemic, intraischemic, and also postreperfusion in the same animal. Moreover, LSF does not inform us about CBF differences in subcortical gray and white matter. Iodoantipyrine autoradiography would be more appropriate for such an assessment. Iodoantipyrine autoradiography, arterial spin labeling, and diffusion tensor imaging are the techniques which can be used in future studies to examine the association between cortical and subcortical white matter CBF. 40 Another caveat is that we only focused on the acute stage of MCAO for structural analysis of CBF; whether microvascular density postischemia changes overtime to cause a difference between young and aged animals needs further investigation. All the animals involved in this study were males, and we did not examine whether there is a difference in CBF changes between young and aged female animals. Sex differences in age-related CBF changes after ischemia could exist as females exhibit different stroke phenotypes than their male counterparts at either young or old age, 41 which is one of the on-going projects by our research group.
In conclusion, young and aged animals exhibit equivalent levels of CBF throughout ischemia, and the age-specific stroke phenotype seems to be unrelated to CBF/perfusion changes in stroke. Microvascular density in the ischemic brain was not different between young and aged animals. Aged brains have less IgG immunoreactivity after MCAO than the young group, which is related to the smaller infarct size seen in aged brains. Other molecular mechanisms that are unrelated to acute CBF changes may underlie age-specific stroke phenotypes.
